Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
ClinicalTrials.gov study NCT06737523. IPD Sharing: NO. Countries: 1. Publications: 0.
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04920188. IPD Sharing: NO. Countries: 1. Publications: 0.
CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML
ClinicalTrials.gov study NCT06763666. IPD Sharing: NO. Countries: 1. Publications: 0.
Cladribine Venetoclax in Monocytic AML
ClinicalTrials.gov study NCT06232655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
ClinicalTrials.gov study NCT00074737. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
ClinicalTrials.gov study NCT07259707. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
ClinicalTrials.gov study NCT02937662. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML
ClinicalTrials.gov study NCT05264883. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
ClinicalTrials.gov study NCT00728520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
ClinicalTrials.gov study NCT04803929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC
ClinicalTrials.gov study NCT03978364. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)
ClinicalTrials.gov study NCT05546580. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation
ClinicalTrials.gov study NCT01615757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance
ClinicalTrials.gov study NCT04174612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS
ClinicalTrials.gov study NCT03059615. IPD Sharing: NO. Countries: 1. Publications: 0.
Use of Venetoclax , AML , Sohag , Egypt
ClinicalTrials.gov study NCT06993883. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ClinicalTrials.gov study NCT04771572. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
ClinicalTrials.gov study NCT07130695. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT06548230. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
ClinicalTrials.gov study NCT03709758. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.